1-Jahres-Chart
5-Tage-Chart
| Realtime | Geld | Brief | Zeit |
|---|---|---|---|
| 0,075 | 0,117 | 07.03. |
- Alle
- Pressemitteilungen
- Empfehlungen
- Chartanalysen
- Berichte
| Zeit | Aktuelle Nachrichten Sprache:
Alle DE EN | Leser | Medien | ||
|---|---|---|---|---|---|
| 23.02. | hVIVO PLC - Issue of Equity and Total Voting Rights | - | RNS | ||
| 29.01. | hVIVO PLC - Trading Update | - | RNS | ||
| 27.01. | hVIVO PLC - Notice of Trading Update | - | RNS | ||
| 18.12.25 | hVIVO PLC - Appointment of Non-Executive Director | - | RNS | ||
| 15.12.25 | hVIVO PLC - CEO & CFO Share Purchase | - | RNS | ||
| 12.12.25 | Broker tips: Hvivo, Whitbread, IHG | 3 | Sharecast | ||
| HVIVO Aktie jetzt für 0€ handeln | |||||
| 12.12.25 | Shore Capital hails improved US biotech funding environment for hVIVO | 1 | Sharecast | ||
| 27.11.25 | Hvivo client acquired by MSD in $9.2bn deal | 8 | Sharecast | ||
| 27.11.25 | hVIVO PLC - MSD to acquire Cidara | 24 | RNS | ||
| 20.11.25 | hVIVO PLC - >£5 million CRS contracts signed | - | RNS | ||
| 11.11.25 | hVIVO develops three new human challenge models for viral testing | 3 | Investing.com | ||
| 11.11.25 | hVIVO meldet erfolgreiche Entwicklung von drei neuen humanen Challenge-Modellen | 1 | Investing.com Deutsch | ||
| 11.11.25 | hVIVO PLC - Positive data from novel human challenge models | - | RNS | ||
| 03.11.25 | hVIVO PLC - Presentation at Jefferies Healthcare Conference | - | RNS | ||
| 23.09.25 | HVIVO Slides To Loss In H1 | - | RTTNews | ||
| 23.09.25 | hVIVO PLC - Interim results | - | RNS |
16 Nachrichten in den letzten 12 Monaten
| Unternehmen / Aktien | Aktienkurs | % | Top-Nachrichten | ||
|---|---|---|---|---|---|
| PLUS THERAPEUTICS | 0,290 | -1,33 % | Plus Therapeutics Inc.: Plus Therapeutics Announces New Category III CPT Code for Convection-Enhanced Delivery Used with REYOBIQ | HOUSTON, Feb. 25, 2026 (GLOBE NEWSWIRE) -- Plus Therapeutics, Inc. (NASDAQ: PSTV) (the "Company"), a healthcare company developing and commercializing precision diagnostics and radiopharmaceuticals... ► Artikel lesen | |
| ASENSUS SURGICAL | - | - | GlobalLogic, Asensus ink surgical robotics engineering collab | ||
| JD HEALTH INTERNATIONAL | 5,350 | +2,88 % | HSBC Research Expects JD HEALTH to Maintain Strong Rev. Growth This Yr, Lifts TP to $80 | ||
| LIFEWARD | 6,100 | 0,00 % | Lifeward Ltd.: Lifeward to Acquire Powered Upper Body Exoskeleton with AI Capabilities Designed to Restore Function to Stroke Survivors | IP and technology acquisition is expected to be highly accretive and to advance Lifeward's position as a diversified biomedical innovation companyWill Expand Lifeward's portfolio beyond lower-limb... ► Artikel lesen | |
| EKSO BIONICS | 11,390 | +3,08 % | Applied Digital Corporation: Applied Digital to Spin Out Cloud Business, Proposes Business Combination with EKSO to Launch ChronoScale | DALLAS, Dec. 29, 2025 (GLOBE NEWSWIRE) -- Applied Digital (NASDAQ: APLD), a designer, builder, and operator of high-performance, sustainably engineered data centers and colocation services for artificial... ► Artikel lesen | |
| IMUNON | 2,960 | +6,47 % | Imunon, Inc.: IMUNON Reports Third Quarter 2025 Financial Results and Provides Business Update | R&D Day showcased remarkable Investigator optimism, continued strengthening supportive data, and significant progress with Phase 3 OVATION 3 Study in pursuit of first frontline immunotherapy for advanced... ► Artikel lesen | |
| ROCKWELL MEDICAL | 0,750 | +0,13 % | Why Is Rockwell Medical Gaining Tuesday? | ||
| VIRIDIAN THERAPEUTICS | 24,560 | -5,14 % | Viridian Therapeutics stellt auf TD Cowen Konferenz Strategie für TED-Behandlung vor | ||
| SINTX TECHNOLOGIES | 2,710 | -0,37 % | SINTX setzt auf Filament und Partnerschaften: Neuer Präsident soll SiN/PEEK in 3D-Fertigung bringen | ||
| AETHLON MEDICAL | 1,700 | -9,09 % | Aethlon Medical, Inc.: Aethlon Medical Announces Fiscal Q3 2026 Financial Results and Corporate Update | Clinical and research programs continue to advance, supported by year-to-date cost efficiencies
Conference Call Today at 4:30 p.m. ET
SAN DIEGO, Feb. 12, 2026 /PRNewswire/... ► Artikel lesen | |
| SAVARIA | 16,300 | 0,00 % | Savaria Corporation: Savaria Q4 2025 Adjusted EBITDA Reaches $51.3M, an increase of 19.7% | LAVAL, Québec, March 04, 2026 (GLOBE NEWSWIRE) -- Savaria Corporation ("Savaria") (TSX: SIS), one of the global leaders in the accessibility industry, is pleased to announce its results for fiscal... ► Artikel lesen | |
| STAGEZERO LIFE SCIENCES | 0,028 | -100,00 % | StageZero Life Sciences Ltd.: StageZero Announces Partial Revocation of Failure to File Cease Trade Order and Proposed Financing | ||
| NEURONETICS | 1,280 | +7,20 % | Neuronetics Announces Selected Preliminary Unaudited Fourth Quarter and Full Year 2025 Financial Results | All values provided represent preliminary unaudited results Fourth quarter 2025 revenue of $41.8 million, representing 86% year-over-year growth on an as reported basis and 23% year-over-year growth... ► Artikel lesen | |
| ARCH THERAPEUTICS | - | - | Arch Therapeutics, Inc. - 15-12G, Securities registration termination | ||
| IMAC HOLDINGS | 0,192 | -4,00 % | IMAC Holdings, Inc.: Ignite Proteomics Announces Collaboration with Inova Health on a Biomarker Study for Late-Stage Cancers | The First Precision Oncology Trial to Use a Functional Proteomics and Phosphoproteomics Assay for Treatment Decision Making in a Pan-Tumor Study Golden, CO, Sept. 10, 2025 (GLOBE NEWSWIRE) -- Ignite... ► Artikel lesen |
HVIVO PLC gehört der Branche Gesundheitswesen an. Die relative Kursveränderung beträgt aktuell +4,19 % bei einem Aktienkurs von 0,087 Euro.
VerkaufenHaltenKaufen
■ Verkaufen
■ Halten
■ Kaufen
Sie erhalten auf FinanzNachrichten.de kostenlose Realtime-Aktienkurse von und sowie Kurse und Daten von ARIVA.DE AG.
Weitere Kennzahlen, Fundamentaldaten und Unternehmensinformationen zu HVIVO PLC finden Sie auf Wallstreet Online.